References
- 1Chimed-Ochir O, Takahashi K, Driscoll TR, Takala J, GBD Mortality and causes of Death Collaborators. Global, regional, and national age-sex specific all cause and cause specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015; 385: 117–171. DOI: 10.1016/S0140-6736(14)61682-2
- 2International Agency for Research on Cancer (IARC). Arsenic, Metals, Fibres and Dusts: A Review of Human Carcinogens. 2012. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No 100C.
http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C.pdf . Accessed December 29, 2018. DOI: 10.1016/S0140-6736(07)60412-7 - 3Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos related diseases and historical asbestos consumption: an international analysis. Lancet. 2007; 369: 844–9.
- 4International Labour Organization/World Health Organization. Outline for the Development of National Programmes for the Elimination of Asbestos-Related Diseases. Geneva, Switzerland: International Labour Organization/World Health Organization; 2007.
http://www.who.int/occupational_health/publications/Out_NPEAD_ENG . - 5Collegium Ramazzini. Call for ban: Call for an international ban on asbestos. Scand J Work Environ Health. 1999; 25(6): 633–5.
- 6United States Geological Survey (USGS). 2015 Minerals Yearbook: Asbestos.
https://minerals.usgs.gov/minerals/pubs/commodity/asbestos/myb1-2015-asbes.pdf ; 2016. - 7Oddone E, Bollon J, Nava CR, et al. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040. Cancers. 2021; 13: 3338. DOI: 10.3390/cancers13133338
- 8Marinaccio A, Binazzi A, Marzio DD, et al. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer. 2012; 130(9): 2146–54. Epub 2011 Sep 27. PMID: 21647880. DOI: 10.1002/ijc.26229
- 9
https://www.who.int/data/data-collection-tools/who-mortality-database . - 10
https://it.zhujiworld.com/ . - 11Gasparrini A. Modeling Exposure-Lag-Response Associations with Distributed Lag Non-Linear Models. Stat. Med. 2014; 33: 881–899. DOI: 10.1002/sim.5963
- 12Gasparrini A, Armstrong B. Reducing and meta-analysing estimates from distributed lag non-linear models. BMC Med Res Methodol. 2013; 13(1). DOI: 10.1186/1471-2288-13-1
- 13Delgermaa V, Takahashi K, Park EK, et al. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011; 89: 716–24. DOI: 10.2471/BLT.11.086678
- 14Odgerel CO, Takahashi K, Sorahan T, et al. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017 Dec; 74(12): 851–858. Epub 2017 Sep 2. PMID: 28866609; PMCID: PMC5740549. DOI: 10.1136/oemed-2017-104298
- 15Park EK, Takahashi K, Hoshuyama T, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011; 119(4): 514–8. DOI: 10.1289/ehp.1002845
- 16Takahashi K, Huuskonen M, Tossavainen A, Higashi T, Okubo T, Rantanen J. Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in ten Western countries and Japan. J Occup Health. 1999; 41(1): 8–11. DOI: 10.1539/joh.41.8
- 17Marinaccio A, Montanaro F, Mastrantonio M, et al. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer. 2005; 115(1): 142–7. PMID: 15645436. DOI: 10.1002/ijc.20820
- 18Murayama T, Takahashi K, Natori Y, Kurumatani N. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort-model. Am J Ind Med. 2006; 49: 1–7. DOI: 10.1002/ajim.20246
- 19Tan E, Warren N, Darnton AJ, Hodgson JT. Projection of mesothelioma mortality in Britain using Bayesian methods. Br J Cancer. 2010; 103: 430–6. DOI: 10.1038/sj.bjc.6605781
- 20Jung SH, Kim HR, Koh SB, et al. A decade of malignant mesothelioma surveillance in Korea. Am J Ind Med. 2012 Oct; 55(10): 869–75. DOI: 10.1002/ajim.22065
- 21Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000; 44(8): 565–601. PMID: 11108782. DOI: 10.1016/S0003-4878(00)00045-4
- 22Garabrant DH, Pastula ST. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol. 2018; 361: 127–136. Epub 2018 Aug 2. PMID: 30077661. DOI: 10.1016/j.taap.2018.07.003
- 23Korchevskiy A, Rasmuson JO, Rasmuson EJ, Strode RD. Inhalation unit risk (IUR) of asbestos based on available science. Inhal Toxicol. 2020 A; 32(9–10): 372–374. Epub 2020 Oct 9. PMID: 33032452. DOI: 10.1080/08958378.2020.1829210
- 24Dalsgaard SB, Würtz ET, Hansen J, Røe OD, Omland Ø. Environmental asbestos exposure in childhood and risk of mesothelioma later in life: a long-term follow-up register-based cohort study. Occup Environ Med. 2019; 76(6): 407–413. Epub 2019 Feb 25. PMID: 30804166. DOI: 10.1136/oemed-2018-105392
- 25Reid A, Franklin P, Olsen N, et al. All-cause mortality and cancer incidence among adults exposed to blue asbestos during childhood. Am J Ind Med. 2013; 56(2): 133–45. Epub 2012 Aug 9. PMID: 22886909. DOI: 10.1002/ajim.22103
- 26Reid A, Franklin P, Berry G, et al. Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom. Occup Environ Med. 2018; 75(12): 898–903. Epub 2018 Aug 29. PMID: 30158318. DOI: 10.1136/oemed-2018-105108
- 27Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008; 38(1): 1–47. PMID: 18671157. DOI: 10.1080/10408440802276167
- 28Korchevskiy AA, Wylie AG. Dimensional determinants for the carcinogenic potency of elongate amphibole particles. Inhal Toxicol. 2021; 33(6–8): 244–259. Epub 2021 Oct 6. PMID: 34612763. DOI: 10.1080/08958378.2021.1971340
- 29Korchevskiy AA, Wylie AG. Dimensional characteristics of the major types of amphibole mineral particles and the implications for carcinogenic risk assessment. Inhal Toxicol. 2022; 34(1–2): 24–38. Epub 2022 Jan 10. PMID: 35001771. DOI: 10.1080/08958378.2021.2024304
- 30Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008; 38(1): 49–73. PMID: 18686078. DOI: 10.1080/10408440802273156
- 31
http://www.ibasecretariat.org/ .
